Heart Pump Device Market Size, Share, Growth Analysis, By Product Type(Ventricular assist devices (VADs), Intra-aortic balloon pumps (IABPs), Total artificial heart (TAH)), By Indication(Bridge-to-transplant (BTT), Destination therapy (DT), Bridge-to-recovery (BTR)), By End-user(Hospitals, cardiology centers, ambulatory surgical centers), By Region - Industry Forecast 2024-2031

The heart pump device market is highly competitive, with several key players vying for market share. The competitive landscape is characterized by intense rivalry, continuous technological advancements, strategic collaborations, and product innovations. Some of the prominent players in the market. These companies have a strong global presence and offer a wide range of heart pump devices catering to different indications and patient needs. Additionally, strategic partnerships, acquisitions, and collaborations with other companies and healthcare institutions are common strategies employed by key players to expand their market presence and gain a competitive edge.

Heart Pump Device Market Top Player’s Company Profile

• Abbott Laboratories (US)

• Medtronic PLC (Ireland)

• LivaNova PLC (United Kingdom)

• Berlin Heart GmbH (Germany)

• SynCardia Systems, LLC (US)

• Abiomed, Inc. (US)

• Getinge AB (Sweden)

• Terumo Corporation (Japan)

• Teleflex Incorporated (US)

• Jarvik Heart, Inc. (US)

• Fresenius Medical Care AG & Co. KGaA (Germany)

• Calon Cardio (United Kingdom)

• CardiacAssist, Inc. (US)

• BiVACOR Inc. (Australia)

• Leviticus Cardio Ltd. (Israel)

• CARMAT SA (France)

• FineHeart SA (France)

• MyLVAD (US)

• MicroPort Scientific Corporation (China)

• TandemLife, a LivaNova company (US)

Heart Pump Device Market